| Year |
Citation |
Score |
| 2022 |
Shen S, Rui Y, Wang Y, Su J, Yu XF. SARS-CoV-2, HIV, and HPV: Convergent evolution of selective regulation of cGAS-STING signaling. Journal of Medical Virology. PMID 36229923 DOI: 10.1002/jmv.28220 |
0.34 |
|
| 2019 |
Guo H, Shen S, Li Y, Bi R, Zhang N, Zheng W, Deng Y, Yang Y, Yu XF, Wang C, Wei W. Adenovirus oncoprotein E4orf6 triggers Cullin5 neddylation to activate the CLR5 E3 ligase for p53 degradation. Biochemical and Biophysical Research Communications. PMID 31301771 DOI: 10.1016/J.Bbrc.2019.07.028 |
0.37 |
|
| 2019 |
Guo H, Zhang N, Shen S, Yu XF, Wei W. Determinants of lentiviral Vpx-CRL4 E3 ligase-mediated SAMHD1 degradation in the substrate adaptor protein DCAF1. Biochemical and Biophysical Research Communications. PMID 31003777 DOI: 10.1016/J.Bbrc.2019.04.085 |
0.434 |
|
| 2019 |
Du J, Rui Y, Zheng W, Li P, Kang J, Zhao K, Sun T, Yu XF. Vif-CBFβ interaction is essential for Vif-induced cell cycle arrest. Biochemical and Biophysical Research Communications. PMID 30851937 DOI: 10.1016/j.bbrc.2019.02.136 |
0.301 |
|
| 2019 |
Liu Y, Fu Y, Wang Q, Li M, Zhou Z, Dabbagh D, Fu C, Zhang H, Li S, Zhang T, Gong J, Kong X, Zhai W, Su J, Sun J, ... ... Yu XF, et al. Proteomic profiling of HIV-1 infection of human CD4 T cells identifies PSGL-1 as an HIV restriction factor. Nature Microbiology. PMID 30833724 DOI: 10.1038/S41564-019-0372-2 |
0.402 |
|
| 2018 |
Huan C, Li Z, Ning S, Wang H, Yu XF, Zhang W. Long non-coding RNA uc002yug.2 activates HIV-1 latency through regulating mRNA level of various RUNX1 isoforms and increasing Tat expression. Journal of Virology. PMID 29491162 DOI: 10.1128/JVI.01844-17 |
0.446 |
|
| 2017 |
Zhang N, Guo H, Yang J, Liu G, Li S, Li S, Wang D, Li R, Shu C, Xu H, Wei Z, Huang H, Zhang S, Gao P, Cen S, ... ... Yu XF, et al. The poly-proline tail of SIVmac Vpx provides gain of function for resistance to a cryptic proteasome-dependent degradation pathway. Virology. 511: 23-29. PMID 28803141 DOI: 10.1016/j.virol.2017.07.022 |
0.378 |
|
| 2017 |
Wang H, Guo H, Su J, Rui Y, Zheng W, Gao W, Zhang W, Li Z, Liu G, Wei W, Yu XF. Inhibition of Vpx-mediated SAMHD1 and Vpr-mediated HLTF degradation by selective disruption of viral CRL4 (DCAF1) E3 ubiquitin ligase assembly. Journal of Virology. PMID 28202763 DOI: 10.1128/JVI.00225-17 |
0.334 |
|
| 2017 |
Zheng W, Ling L, Li Z, Wang H, Rui Y, Gao W, Wang S, Su X, Wei W, Yu XF. Conserved interaction of lentiviral Vif molecules with HIV-1 Gag and differential effects of species-specific Vif on virus production. Journal of Virology. PMID 28122978 DOI: 10.1128/JVI.00064-17 |
0.436 |
|
| 2016 |
Wei W, Guo H, Ma M, Markham R, Yu XF. Accumulation of MxB/Mx2-resistant HIV-1 Capsid Variants During Expansion of the HIV-1 Epidemic in Human Populations. Ebiomedicine. 8: 230-236. PMID 27428433 DOI: 10.1016/j.ebiom.2016.04.020 |
0.368 |
|
| 2016 |
An P, Penugonda S, Thorball CW, Bartha I, Goedert JJ, Donfield S, Buchbinder S, Binns-Roemer E, Kirk GD, Zhang W, Fellay J, Yu XF, Winkler CA. Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia. Plos Genetics. 12: e1005921. PMID 26942578 DOI: 10.1371/journal.pgen.1005921 |
0.383 |
|
| 2016 |
Han Z, Lv M, Shi Y, Yu J, Niu J, Yu XF, Zhang W. Mutation of Glycosylation Sites in BST-2 Leads to Its Accumulation at Intracellular CD63-Positive Vesicles without Affecting Its Antiviral Activity against Multivesicular Body-Targeted HIV-1 and Hepatitis B Virus. Viruses. 8. PMID 26938549 DOI: 10.3390/V8030062 |
0.334 |
|
| 2016 |
Wei W, Yu XF. HIV-1 Envelope Under Attack. Trends in Microbiology. PMID 26803378 DOI: 10.1016/j.tim.2016.01.004 |
0.336 |
|
| 2016 |
Kang J, Hou J, Zhao K, Yu XF, Du J. HD Domain of SAMHD1 Influences Vpx-Induced Degradation at a Post-Interaction Step. Biochemical and Biophysical Research Communications. PMID 26779819 DOI: 10.1016/j.bbrc.2016.01.080 |
0.385 |
|
| 2015 |
Liu X, Guo H, Wang H, Markham R, Wei W, Yu XF. HIV-1 Vpr suppresses the cytomegalovirus promoter in a CRL4(DCAF1) E3 ligase independent manner. Biochemical and Biophysical Research Communications. 459: 214-9. PMID 25704090 DOI: 10.1016/j.bbrc.2015.02.060 |
0.406 |
|
| 2015 |
Wei W, Yu XF. HIV-1/HIV-2 versus SAMHD1 restriction: a tale of two viruses. Cell Host & Microbe. 17: 8-9. PMID 25590755 DOI: 10.1016/j.chom.2014.12.005 |
0.356 |
|
| 2015 |
Zhao K, Du J, Rui Y, Zheng W, Kang J, Hou J, Wang K, Zhang W, Simon VA, Yu XF. Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif. Cell Cycle (Georgetown, Tex.). 14: 838-47. PMID 25590520 DOI: 10.1080/15384101.2014.1000212 |
0.355 |
|
| 2015 |
Xu B, Kong J, Wang X, Wei W, Xie W, Yu XF. Structural insight into the assembly of human anti-HIV dynamin-like protein MxB/Mx2. Biochemical and Biophysical Research Communications. 456: 197-201. PMID 25446123 DOI: 10.1016/j.bbrc.2014.11.058 |
0.381 |
|
| 2014 |
Kong J, Xu B, Wei W, Wang X, Xie W, Yu XF. Characterization of the amino-terminal domain of Mx2/MxB-dependent interaction with the HIV-1 capsid. Protein & Cell. 5: 954-7. PMID 25363729 DOI: 10.1007/s13238-014-0113-5 |
0.311 |
|
| 2014 |
Zhang W, Wang H, Li Z, Liu X, Liu G, Harris RS, Yu XF. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins. Journal of Virology. 88: 12528-40. PMID 25142583 DOI: 10.1128/Jvi.02072-14 |
0.379 |
|
| 2014 |
Zhao K, Du J, Zheng W, Yu XF. HIV-1 transmission among injection drug users leads to novel recombinants circulating in southern China. Aids Research and Human Retroviruses. 30: 1006-9. PMID 25103676 DOI: 10.1089/AID.2014.0036 |
0.346 |
|
| 2014 |
Yan M, Zhao K, Du J, Li L, Wu D, Xu S, Zeng X, Wang G, Yu XF. HIV-1 diversity and drug-resistant mutations in infected individuals in Changchun, China. Plos One. 9: e100540. PMID 24945273 DOI: 10.1371/journal.pone.0100540 |
0.377 |
|
| 2014 |
Evans SL, Schön A, Gao Q, Han X, Zhou X, Freire E, Yu XF. HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3. Retrovirology. 11: 4. PMID 24422669 DOI: 10.1186/1742-4690-11-4 |
0.305 |
|
| 2014 |
Han X, Liang W, Hua D, Zhou X, Du J, Evans SL, Gao Q, Wang H, Viqueira R, Wei W, Zhang W, Yu XF. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase. Journal of Virology. 88: 3320-8. PMID 24390335 DOI: 10.1128/JVI.03833-13 |
0.416 |
|
| 2014 |
Zhou X, Han X, Zhao K, Du J, Evans SL, Wang H, Li P, Zheng W, Rui Y, Kang J, Yu XF. Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression. Journal of Virology. 88: 2555-63. PMID 24352440 DOI: 10.1128/JVI.03604-13 |
0.425 |
|
| 2014 |
Wei W, Guo H, Gao Q, Markham R, Yu XF. Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins. Journal of Virology. 88: 583-91. PMID 24173216 DOI: 10.1128/Jvi.02866-13 |
0.413 |
|
| 2014 |
Wei W, Guo H, Liu X, Zhang H, Qian L, Luo K, Markham RB, Yu XF. A first-in-class NAE inhibitor, MLN4924, blocks lentiviral infection in myeloid cells by disrupting neddylation-dependent Vpx-mediated SAMHD1 degradation. Journal of Virology. 88: 745-51. PMID 24155378 DOI: 10.1128/Jvi.02568-13 |
0.36 |
|
| 2013 |
Qi H, Zhao K, Xu F, Zhang X, Zhang Z, Yang L, Li C, Liang X, Guo W, Chen S, Liu Z, Zhang W, Yu XF. HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China. Plos One. 8: e68656. PMID 23869225 DOI: 10.1371/journal.pone.0068656 |
0.32 |
|
| 2012 |
Zhen A, Du J, Zhou X, Xiong Y, Yu XF. Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities. Plos One. 7: e38771. PMID 22859935 DOI: 10.1371/Journal.Pone.0038771 |
0.682 |
|
| 2012 |
Wei W, Guo H, Han X, Liu X, Zhou X, Zhang W, Yu XF. A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest. Cellular Microbiology. 14: 1745-56. PMID 22776683 DOI: 10.1111/j.1462-5822.2012.01835.x |
0.363 |
|
| 2012 |
Zhou X, Evans SL, Han X, Liu Y, Yu XF. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components. Plos One. 7: e33495. PMID 22479405 DOI: 10.1371/journal.pone.0033495 |
0.421 |
|
| 2010 |
Zhang W, Du J, Yu K, Wang T, Yong X, Yu XF. Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions. Journal of Virology. 84: 12903-13. PMID 20926562 DOI: 10.1128/JVI.01632-10 |
0.426 |
|
| 2010 |
Shang H, Zhong P, Liu J, Han X, Dai D, Zhang M, Zhao K, Xu R, Yu XF. High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China. Plos One. 5: e10631. PMID 20523729 DOI: 10.1371/journal.pone.0010631 |
0.325 |
|
| 2010 |
Zhen A, Wang T, Zhao K, Xiong Y, Yu XF. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity. Journal of Virology. 84: 1902-11. PMID 19939923 DOI: 10.1128/Jvi.01509-09 |
0.701 |
|
| 2009 |
Niewiadomska AM, Yu XF. Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif. Current Topics in Microbiology and Immunology. 339: 1-25. PMID 20012521 DOI: 10.1007/978-3-642-02175-6_1 |
0.766 |
|
| 2009 |
Ehrlich ES, Wang T, Luo K, Xiao Z, Niewiadomska AM, Martinez T, Xu W, Neckers L, Yu XF. Regulation of Hsp90 client proteins by a Cullin5-RING E3 ubiquitin ligase. Proceedings of the National Academy of Sciences of the United States of America. 106: 20330-5. PMID 19933325 DOI: 10.1073/Pnas.0810571106 |
0.7 |
|
| 2009 |
An P, Johnson R, Phair J, Kirk GD, Yu XF, Donfield S, Buchbinder S, Goedert JJ, Winkler CA. APOBEC3B deletion and risk of HIV-1 acquisition. The Journal of Infectious Diseases. 200: 1054-8. PMID 19698078 DOI: 10.1086/605644 |
0.383 |
|
| 2009 |
Chen G, He Z, Wang T, Xu R, Yu XF. A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G. Journal of Virology. 83: 8674-82. PMID 19535450 DOI: 10.1128/JVI.00653-09 |
0.363 |
|
| 2009 |
Tan L, Sarkis PT, Wang T, Tian C, Yu XF. Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 279-87. PMID 18827027 DOI: 10.1096/Fj.07-088781 |
0.304 |
|
| 2008 |
Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins. Plos One. 3: e3963. PMID 19088851 DOI: 10.1371/Journal.Pone.0003963 |
0.76 |
|
| 2008 |
He Z, Zhang W, Chen G, Xu R, Yu XF. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. Journal of Molecular Biology. 381: 1000-11. PMID 18619467 DOI: 10.1016/j.jmb.2008.06.061 |
0.41 |
|
| 2008 |
Stanley BJ, Ehrlich ES, Short L, Yu Y, Xiao Z, Yu XF, Xiong Y. Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. Journal of Virology. 82: 8656-63. PMID 18562529 DOI: 10.1128/Jvi.00767-08 |
0.374 |
|
| 2008 |
Wang T, Zhang W, Tian C, Liu B, Yu Y, Ding L, Spearman P, Yu XF. Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C. Virology. 377: 71-9. PMID 18495196 DOI: 10.1016/J.Virol.2008.04.012 |
0.437 |
|
| 2008 |
Wang J, Shackelford JM, Selliah N, Shivers DK, O'Neill E, Garcia JV, Muthumani K, Weiner D, Yu XF, Gabuzda D, Finkel TH. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest. Dna and Cell Biology. 27: 267-77. PMID 18462066 DOI: 10.1089/Dna.2007.0707 |
0.364 |
|
| 2008 |
Zhang W, Huang M, Wang T, Tan L, Tian C, Yu X, Kong W, Yu XF. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases. Cellular Microbiology. 10: 1662-75. PMID 18419775 DOI: 10.1111/J.1462-5822.2008.01157.X |
0.39 |
|
| 2008 |
Garten RJ, Lai SH, Zhang JB, Liu W, Chen J, Yu XF. Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China. World Journal of Gastroenterology. 14: 1878-84. PMID 18350626 DOI: 10.3748/Wjg.14.1878 |
0.597 |
|
| 2008 |
García M, Yu XF, Griffin DE, Moss WJ. Measles virus inhibits human immunodeficiency virus type 1 reverse transcription and replication by blocking cell-cycle progression of CD4+ T lymphocytes. The Journal of General Virology. 89: 984-93. PMID 18343840 DOI: 10.1099/Vir.0.83601-0 |
0.412 |
|
| 2008 |
Wang T, Tian C, Zhang W, Sarkis PT, Yu XF. Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging. Journal of Molecular Biology. 375: 1098-112. PMID 18067920 DOI: 10.1016/j.jmb.2007.11.017 |
0.4 |
|
| 2007 |
Tian C, Wang T, Zhang W, Yu XF. Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles. Nucleic Acids Research. 35: 7288-302. PMID 17959647 DOI: 10.1093/nar/gkm816 |
0.334 |
|
| 2007 |
Xiao Z, Xiong Y, Zhang W, Tan L, Ehrlich E, Guo D, Yu XF. Characterization of a novel Cullin5 binding domain in HIV-1 Vif. Journal of Molecular Biology. 373: 541-50. PMID 17869271 DOI: 10.1016/J.Jmb.2007.07.029 |
0.396 |
|
| 2007 |
Tan L, Ehrlich E, Yu XF. DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest. Journal of Virology. 81: 10822-30. PMID 17626091 DOI: 10.1128/Jvi.01380-07 |
0.305 |
|
| 2007 |
Niewiadomska AM, Tian C, Tan L, Wang T, Sarkis PT, Yu XF. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. Journal of Virology. 81: 9577-83. PMID 17582006 DOI: 10.1128/Jvi.02800-06 |
0.723 |
|
| 2007 |
Luo K, Wang T, Liu B, Tian C, Xiao Z, Kappes J, Yu XF. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation. Journal of Virology. 81: 7238-48. PMID 17428847 DOI: 10.1128/Jvi.02584-06 |
0.357 |
|
| 2007 |
Ying S, Zhang X, Sarkis PT, Xu R, Yu X. Cell-specific regulation of APOBEC3F by interferons. Acta Biochimica Et Biophysica Sinica. 39: 297-304. PMID 17417686 DOI: 10.1111/J.1745-7270.2007.00275.X |
0.31 |
|
| 2007 |
Xiao Z, Ehrlich E, Luo K, Xiong Y, Yu XF. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 217-22. PMID 17135358 DOI: 10.1096/fj.06-6773com |
0.332 |
|
| 2007 |
Wang J, Shackelford JM, Casella CR, Shivers DK, Rapaport EL, Liu B, Yu XF, Finkel TH. The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells. Virology. 359: 243-52. PMID 17056089 DOI: 10.1016/j.virol.2006.09.026 |
0.375 |
|
| 2006 |
Xiao Z, Ehrlich E, Yu Y, Luo K, Wang T, Tian C, Yu XF. Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif. Virology. 349: 290-9. PMID 16530799 DOI: 10.1016/j.virol.2006.02.002 |
0.321 |
|
| 2006 |
Tian C, Yu X, Zhang W, Wang T, Xu R, Yu XF. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F. Journal of Virology. 80: 3112-5. PMID 16501124 DOI: 10.1128/Jvi.80.6.3112-3115.2006 |
0.492 |
|
| 2005 |
Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: S18-24. PMID 16265609 DOI: 10.1086/429491 |
0.656 |
|
| 2005 |
García M, Yu XF, Griffin DE, Moss WJ. In vitro suppression of human immunodeficiency virus type 1 replication by measles virus. Journal of Virology. 79: 9197-205. PMID 15994814 DOI: 10.1128/Jvi.79.14.9197-9205.2005 |
0.502 |
|
| 2005 |
Duggal P, Winkler CA, An P, Yu XF, Farzadegan H, O'Brien SJ, Beaty TH, Vlahov D. The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 38: 584-9. PMID 15793370 DOI: 10.1097/01.Qai.0000134741.49208.03 |
0.375 |
|
| 2005 |
Laeyendecker O, Zhang GW, Quinn TC, Garten R, Ray SC, Lai S, Liu W, Chen J, Yu XF. Molecular epidemiology of HIV-1 subtypes in southern China. Journal of Acquired Immune Deficiency Syndromes (1999). 38: 356-62. PMID 15735457 |
0.644 |
|
| 2005 |
Quinnan GV, Yu XF, Lewis MG, Zhang PF, Sutter G, Silvera P, Dong M, Choudhary A, Sarkis PT, Bouma P, Zhang Z, Montefiori DC, Vancott TC, Broder CC. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells. Journal of Virology. 79: 3358-69. PMID 15731230 DOI: 10.1128/Jvi.79.6.3358-3369.2005 |
0.427 |
|
| 2004 |
Yu Y, Xiao Z, Ehrlich ES, Yu X, Yu XF. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes & Development. 18: 2867-72. PMID 15574593 DOI: 10.1101/Gad.1250204 |
0.462 |
|
| 2004 |
Luo K, Liu B, Xiao Z, Yu Y, Yu X, Gorelick R, Yu XF. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. Journal of Virology. 78: 11841-52. PMID 15479826 DOI: 10.1128/Jvi.78.21.11841-11852.2004 |
0.539 |
|
| 2004 |
Paillart JC, Dettenhofer M, Yu XF, Ehresmann C, Ehresmann B, Marquet R. First snapshots of the HIV-1 RNA structure in infected cells and in virions. The Journal of Biological Chemistry. 279: 48397-403. PMID 15355993 DOI: 10.1074/Jbc.M408294200 |
0.725 |
|
| 2004 |
Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, Yu XF. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. International Journal of Epidemiology. 33: 182-8. PMID 15075167 DOI: 10.1093/Ije/Dyh019 |
0.578 |
|
| 2004 |
Liu B, Yu X, Luo K, Yu Y, Yu XF. Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G Journal of Virology. 78: 2072-2081. PMID 14747572 DOI: 10.1128/Jvi.78.4.2072-2081.2004 |
0.541 |
|
| 2003 |
Yu XF, Wang X, Mao P, Wang S, Li Z, Zhang J, Garten R, Kong W, Lai S. Characterization of HIV type 1 heterosexual transmission in Yunnan, China. Aids Research and Human Retroviruses. 19: 1051-5. PMID 14686326 DOI: 10.1089/088922203322588422 |
0.66 |
|
| 2003 |
Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science (New York, N.Y.). 302: 1056-60. PMID 14564014 DOI: 10.1126/Science.1089591 |
0.515 |
|
| 2003 |
Dong M, Zhang PF, Grieder F, Lee J, Krishnamurthy G, VanCott T, Broder C, Polonis VR, Yu XF, Shao Y, Faix D, Valente P, Quinnan GV. Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system. Journal of Virology. 77: 3119-30. PMID 12584337 DOI: 10.1128/Jvi.77.5.3119-3130.2003 |
0.311 |
|
| 2003 |
Kao S, Akari H, Khan MA, Dettenhofer M, Yu XF, Strebel K. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection. Journal of Virology. 77: 1131-40. PMID 12502829 DOI: 10.1128/Jvi.77.2.1131-1140.2003 |
0.716 |
|
| 2002 |
Kong W, Tian C, Liu B, Yu XF. Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic sindbis virus vector. Journal of Virology. 76: 11434-9. PMID 12388704 DOI: 10.1128/JVI.76.22.11434-11439.2002 |
0.395 |
|
| 2002 |
Speck RR, Yu XF, Hildreth J, Flexner C. Differential effects of p-glycoprotein and multidrug resistance protein-1 on productive human immunodeficiency virus infection. The Journal of Infectious Diseases. 186: 332-40. PMID 12134229 DOI: 10.1086/341464 |
0.487 |
|
| 2002 |
Yu XF, Liu W, Chen J, Kong W, Liu B, Zhu Q, Liang F, McCutchan F, Piyasirisilp S, Lai S. Maintaining low HIV type 1 env genetic diversity among injection drug users infected with a B/C recombinant and CRF01_AE HIV type 1 in southern China. Aids Research and Human Retroviruses. 18: 167-70. PMID 11839150 DOI: 10.1089/08892220252779719 |
0.46 |
|
| 2000 |
Piyasirisilp S, McCutchan FE, Carr JK, Sanders-Buell E, Liu W, Chen J, Wagner R, Wolf H, Shao Y, Lai S, Beyrer C, Yu XF. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. Journal of Virology. 74: 11286-95. PMID 11070028 DOI: 10.1128/Jvi.74.23.11286-11295.2000 |
0.479 |
|
| 2000 |
Dettenhofer M, Cen S, Carlson BA, Kleiman L, Yu XF. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription. Journal of Virology. 74: 8938-45. PMID 10982337 DOI: 10.1128/Jvi.74.19.8938-8945.2000 |
0.751 |
|
| 2000 |
Speck RR, Flexner C, Tian CJ, Yu XF. Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitors. Antimicrobial Agents and Chemotherapy. 44: 1397-403. PMID 10770790 DOI: 10.1128/Aac.44.5.1397-1403.2000 |
0.507 |
|
| 1998 |
Wang Z, Lyles CM, Beyrer C, Celentano DD, Vlahov D, Natpratan C, Markham R, Khamboonruang C, Nelson K, Yu XF. Diversification of subtype e human immunodeficiency virus type 1 env in heterosexual seroconverters from Northern Thailand Journal of Infectious Diseases. 178: 1507-1511. PMID 9780276 DOI: 10.1086/314441 |
0.497 |
|
| 1997 |
Yu XF, Wang Z, Beyrer C, Celentano DD, Khamboonruang C, Nelson K. Diversity of full-length subtype E HIV type 1 env sequences in early seroconvertors from northern Thailand Aids Research and Human Retroviruses. 13: 1439-1441. PMID 9359664 DOI: 10.1089/Aid.1997.13.1439 |
0.433 |
|
| 1996 |
Egan MA, Carruth LM, Rowell JF, Yu X, Siliciano RF. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. Journal of Virology. 70: 6547-56. PMID 8794289 DOI: 10.1128/Jvi.70.10.6547-6556.1996 |
0.482 |
|
| 1995 |
Yu XF, Wang Z, Beyrer C, Celentano DD, Khamboonruang C, Allen E, Nelson K. Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in Northern Thailand Journal of Virology. 69: 4649-4655. PMID 7609029 DOI: 10.1128/Jvi.69.8.4649-4655.1995 |
0.47 |
|
| 1994 |
Yu QC, Matsuda Z, Yu X, Ito S, Essex M, Lee TH. An electron-lucent region within the virion distinguishes HIV-1 from HIV-2 and simian immunodeficiency virus. Aids Research and Human Retroviruses. 10: 757-61. PMID 8074937 DOI: 10.1089/Aid.1994.10.757 |
0.488 |
|
| 1994 |
Yu X, Mclane MF, Ratner L, O'Brien W, Collman R, Essex M, Lee TH. Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1 Proceedings of the National Academy of Sciences of the United States of America. 91: 10237-10241. PMID 7937869 DOI: 10.1073/Pnas.91.21.10237 |
0.432 |
|
| 1993 |
Yuan X, Yu X, Lee TH, Essex M. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor Journal of Virology. 67: 6387-6394. PMID 8411340 DOI: 10.1128/Jvi.67.11.6387-6394.1993 |
0.358 |
|
| Show low-probability matches. |